However, the biology behind the fascinating ABO‐pancreatic cancer link is poorly understood, and studies are warranted on how ABO glycosyltransferase activity may influence biological aggressiveness of pancreatic neoplastic cells. This evidence concerns the gene ABO and familial pancreatic carcinoma.